Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Fink Ya"'
Autor:
Richard N. Bergman, Mary Walter, Peter Herscovitch, Yaron Rotman, Joyce D. Linderman, Fink Ya, Alison S. Baskin, Marilyn Ader, James W. Johnson, Chen Ky, Zahraa Abdul Sater, Robert J. Brychta, Francesca Piccinini, Suzanne McGehee, Laura A. Fletcher, Norman B. Javitt, William Dieckmann, Cai H, Corina Millo, Devika Kapuria, ero C, Peter Walter, Thomas M. Cassimatis, Alana E O'Mara, Brooks P. Leitner, Kelsey N, Aaron M. Cypess
Publikováno v:
J Clin Invest
BACKGROUND: Mirabegron is a β3-adrenergic receptor (β3-AR) agonist approved only for the treatment of overactive bladder. Encouraging preclinical results suggest that β3-AR agonists could also improve obesity-related metabolic disease by increasin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::205ae0ed58abe4365ef446ae9710878c
https://doi.org/10.1172/jci131126
https://doi.org/10.1172/jci131126
Autor:
O'Mara AE; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Johnson JW; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Linderman JD; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Brychta RJ; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., McGehee S; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Fletcher LA; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Fink YA; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Kapuria D; Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland, USA., Cassimatis TM; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Kelsey N; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Cero C; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Sater ZA; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Piccinini F; Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Baskin AS; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Leitner BP; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Cai H; Clinical Mass Spectrometry Core, NIDDK, NIH, Bethesda, Maryland, USA., Millo CM; Positron Emission Tomography Department, NIH, Bethesda, Maryland, USA., Dieckmann W; Positron Emission Tomography Department, NIH, Bethesda, Maryland, USA., Walter M; Clinical Laboratory Core, NIDDK, NIH, Bethesda, Maryland, USA., Javitt NB; Departments of Medicine and Pediatrics, NYU School of Medicine, New York, New York, USA., Rotman Y; Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland, USA., Walter PJ; Clinical Mass Spectrometry Core, NIDDK, NIH, Bethesda, Maryland, USA., Ader M; Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Bergman RN; Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Herscovitch P; Positron Emission Tomography Department, NIH, Bethesda, Maryland, USA., Chen KY; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Cypess AM; Diabetes, Endocrinology, and Obesity Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2020 May 01; Vol. 130 (5), pp. 2209-2219.